Fibrocystic breast changes
ICD-10 N60.1; N60.2; N60.3 · ICD-11 GB20.0

First-Line Management of Fibrocystic Breast Changes: Lifestyle and Supportive Approach

Fibrocystic breast changes are a common benign condition presenting with cyclic breast discomfort. This first-line protocol prioritises non-pharmacological measures before any pharmacological escalation is considered.

Clinical Goals

The primary targets are improvement and reduction in cyclic breast pain, tenderness, and swelling.

Approach Overview

Management begins with reassurance, education, and counseling. Physical supportive measures and targeted guidance on dietary and lifestyle habits are the foundation of the initial treatment plan.

The complete structured regimen — including specific recommendations, sequencing, and criteria for advancing to the next step — is available in the full protocol.

References

  • By general convention, fibrocystic changes are considered as normal consequences of breast development and involution and hence, education and counseling should be the first line of treatment in addition to the clinical examination and imaging of breast to rule out any major pathology.
  • Reassurance, counseling and advice to wear a properly supporting bra should be the first prescription.
  • Comfortable supporting brassieres during day and night hours are advised to provide support and reduce tension on supporting ligaments of breast.
  • Changes in diet pattern (low saturated fats) and abstinence from certain substances (caffeine, nicotine) can be advised and pharmacological interventions should begin with therapies like EPO which are safer than the hormonal or hormone-modulating drugs.
  • Dietary fat restrictions has shown significant improvement in cyclic breast pain, tenderness and swelling but not in non-cyclic pain.
View source ↗